Navigation Links
PAREXEL Completes 200 Patient Studies In Its Early Phase Units Over Three Years
Date:11/17/2010

and access to local healthcare professionals through PAREXEL's hospital-based units.  PAREXEL's early phase units are strategically located to facilitate rapid patient recruitment.  

As biopharmaceutical companies strive to manage development costs, gather dose range data sooner, accelerate development timelines, and obtain earlier efficacy signals, PAREXEL helps meet these multiple goals in early stage development.  PAREXEL's early phase services provide fully integrated solutions from First in Man through Proof-of-Concept and help biopharmaceutical companies seeking to return solid, reproducible outcomes to succeed in later-phase trials.

PAREXEL's early phase units are located across three continents, including in Baltimore and Los Angeles in the United States; London, United Kingdom; Berlin, Germany; and Bloemfontein, George, and Port Elizabeth, South Africa. PAREXEL's early phase capabilities include a full scope of early phase studies, specialized trial design, state-of-the-art technologies, hospital-based resources, and scientific expertise as well as vast experience in the oncology, neurology, cardiology, respiratory, and metabolism/endocrine therapeutic areas. For more information about PAREXEL's early phase capabilities visit: http://www.PAREXEL.com/Early_Phase.html.

About PAREXEL International PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug de
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Team completes world-first ocean observatory
2. University of Hawaii completes 3-year investigation of military munitions sea disposal site
3. Kornberg Associates
4. Architects Completes UC Riverside Stem Cell Core Facility Project
5. KINAXO Completes Financing Round to Enhance Biomarker Development
6. Pacific Biometrics Completes $4 Million Debt Financing
7. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
8. Lockheed Martin Team Completes Key Design Milestone on Federal Bureau of Investigations Next Generation Identification Program
9. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
10. DOE Joint Genome Institute completes soybean genome
11. Arsenic early in treatment improves survival for leukemia patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... April 2, 2015 Fingerprint Cards ... sensor FPC1025 from the distributor World Peace Industrial Group ... Q2 2015 although the major part of the shipments ... be used by smartphone manufacturers in China ... included in the communicated revenue guidance of + 1 000 ...
(Date:3/30/2015)... 26, 2015 Research and Markets ( ... "Global Gesture Recognition Market in Automotive Sector 2014-2018" ... the Global Gesture Recognition market in Automotive Sector to ... 2013-2018. Gesture recognition is the ability of ... of an individual. Gesture recognition technology can be 2D-based ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... From an environmental perspective, Daphnia pulex ... on the planet. Scientists know how this species responds ... important model for ecological and evolutionary research. Its genome, ... and genes interact. Until now. An international team ...
... evolutionary past, stress often meant imminent danger, and ... our body,s stress response is to stock-pile blood-clotting ... (MMPU), a collaboration between the European Molecular Biology ... of Heidelberg Medical Centre, have discovered how stressed ...
... found in 68 percent of dairy herds and causes ... US dairy industry. A contagious, chronic and usually fatal ... reduces a cow,s milk production, causes weight loss in ... animals., The National Institute for Mathematical and Biological Synthesis ...
Cached Biology News:Massive Daphnia genome leads to understanding gene-environment interactions 2Massive Daphnia genome leads to understanding gene-environment interactions 3Blood-clotting protein linked to cancer and septicemia 2Blood-clotting protein linked to cancer and septicemia 3Wasting disease in cattle focus of workshop 2
(Date:5/6/2015)... Park Systems , world-leader in ... high vacuum AFM system in the market that meets ... manufacturing. Park NX-Hivac is ideal for academic and industrial ... highly doped semiconductor processing where more highly sophisticated failure ... vacuum scanning spreading resistance microscopy (SSRM) of Park NX-Hivac ...
(Date:5/6/2015)... 06, 2015 Histogen, Inc., a ... products of cells grown under simulated embryonic conditions, ... treatment candidate for melanoma during the 2015 Society ... May 6-9, 2015 in Atlanta, GA. , Histogen ... a soluble material with anti-oncologic properties, with potential ...
(Date:5/6/2015)... 2015 The Remedy Group , ... for the specialty pharmacy industry, will be exhibiting, presenting, ... Specialty Pharmacy Summit. The Summit will be held May ... and is the largest annual gathering for the specialty ... from pharmacy providers, pharma/biotech manufacturers, and payers, to learn ...
(Date:5/5/2015)... May 5, 2015  Blueprint Medicines (NASDAQ: ... initial public offering of 9,367,708 shares of common ... per share, including shares of common stock issued ... their option to purchase additional shares. The gross ... Medicines were approximately $168.6 million, before underwriting discounts and ...
Breaking Biology Technology:Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 2Blueprint Medicines Announces Closing of Initial Public Offering 2
... in Principle Reached to Terminate Marketing Agreement with Triax ... Pyratine-6(TM) on Most Favorable Terms, NAPA, Calif., May ... Sciences company engaged in the development,of technologies that target ... the quarter ended March 31, 2008 and an agreement ...
... Highest-risk precancerous condition of esophagus eliminated in 90 percent ... ... 15 BARRX Medical, Inc., the,global technology leader for treating precancerous ... patients in a,multi-center U.S. study were free of the highest-risk of ...
... million or 11 cents ... per share ... Inc. (OTC Bulletin Board: CBPO) ("CBP" or the,"Company"), one of the ... reported financial results for,the first quarter ended on March 31, 2008., ...
Cached Biology Technology:Senetek PLC Reports First Quarter 2008 Financial Results 2Senetek PLC Reports First Quarter 2008 Financial Results 3New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 2New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 3China Biologic Products Reports First Quarter 2008 Results 2China Biologic Products Reports First Quarter 2008 Results 3China Biologic Products Reports First Quarter 2008 Results 4China Biologic Products Reports First Quarter 2008 Results 5China Biologic Products Reports First Quarter 2008 Results 6China Biologic Products Reports First Quarter 2008 Results 7China Biologic Products Reports First Quarter 2008 Results 8China Biologic Products Reports First Quarter 2008 Results 9China Biologic Products Reports First Quarter 2008 Results 10
... microarrays containing peptidomimetics built on the ... synthesis platform. These microarrays are available ... Peptide Microarray Service. Custom ... completely customer specified. Thousands of customer ...
... OPEP-01009 is a 16 amino acid (amino acids 3-18) synthetic ... The sequence of this peptide is (amino to carboxy ... - V - K - L - R - A ... - K(18). This peptide may be used for ...
... is the industry standard microarray image analysis ... imaging and analysis tools, visualizations, automation capabilities, ... is included with every GenePix scanner, and ... scanners and all types of arrays. A ...
... Superior Protein Detection and Quantitation Over ... Proteomic Imaging System is a highly sensitive ... life science research applications. ProXPRESS 2D provides ... dyes in the UV and VIS spectrum ...
Biology Products: